Objective: This study was designed to compare the diagnostic accuracy of Pipelle endometrial sampling with conventional dilatation & curettage in patients with abnormal uterine bleeding.
Introduction
Abnormal uterine bleeding is a major gynecological problem, accounting for 33% of outpatient referrals, including 69% of referrals in the peri-menopausal and postmenopausal age groups (1) . Evaluation of the abnormal uterine bleeding in women ≥40 years or menopausal women is of critical importance to confirm the benign nature of the problem and to Abstract Özet exclude endometrial carcinoma, so that medical or conservative treatment can be offered and unnecessary radical surgery can be avoided (2) . Dilatation & curettage (D&C) is the gold standard for endometrial sampling, but in 60% of cases, less than half of the uterine cavity is curetted, with the added risk of general anesthesia, infection and perforation (3, 4) . This has led to the advent of new and simple methods for endometrial sampling. Various devices are on the market nowadays, including the Pipelle device (5, 6) . The Pipelle can be used on an outpatient basis and is cost effective compared with D&C (7) . However, there are still concerns regarding the adequacy of the sample obtained, nonsampling of focal intrauterine lesions (6) . Therefore, this study was designed to compare the diagnostic accuracy of Pipelle endometrial sampling with conventional D&C in patients with abnormal uterine bleeding.
Material and Methods
Over one year, patients with abnormal uterine bleeding over 40 years, were included in this comparative study. Detailed clinical assessment of the patients was followed by transvaginal sonography and laboratory investigations (CBC, coagulation profile, prolactin, thyroid and liver function tests). Patients with local gynecological cause or possibility of pregnancy or history of contraception or endometrial thickness <4 mm were excluded from the study. One Hundred and Forty-three patients were included in this study after informed consent and approval of the study protocol by the institute ethics committee. Patients included in this study were euthyroid with normal liver function tests, normal activated partial thromboplastin time (APTT) and normal platelet count. The endometrial sampling was performed by the Pipelle device in the ward prior to premedication ordered by the anesthetist. The Pipelle (Endocurrette, Midvale, Utah, USA) was introduced without performing cervical dilatation and withdrawn outside the uterus with a rotatory movement to get the sample which was labeled as sample A. The patients were then transferred to the operative theatre for D&C and the obtained sample after D&C was labeled as sample B. Both samples were sent to a pathologist, who was blinded to the methods of sampling and patients' medical history for histopathology assessment. The histopathology reports of the Pipelle sample was compared with that of the D&C sample and the D&C report was considered as the gold standard.
Results
Failure of the procedure was inability to introduce the Pipelle without cervical dilatation in three attempts (3 patients were excluded due to failure to introduce the Pipelle through the cervix to get the endometrial sample and the samples were obtained in those patients by D&C). After exclusion of those 3 patients, 140 patients with abnormal uterine bleeding were included in this study, the median age of the studied population was 44.5 years and median age of menarche was 13.5 years, while the median parity was 3.5 and median endometrial thickness was 11 cm, Table 1 .
The presenting symptoms of the studied cases were; menorrhagia (n=53), polymenorrhagia (n=37), metrorrhagia or irregular bleeding (n=26) and postmenopausal bleeding (n=24). The sample was labeled as inadequate by the histopathologist when no endometrial tissue was present in the specimen sent. 100% of the samples obtained by D&C, while 97.9% of the samples obtained by Pipelle device were adequate for histopathological examination. The histopathological examination of 140 samples obtained by conventional D&C revealed; proliferative endometrium in 37 specimens, secretory endometrium in 33 specimens, endometrial hyperplasia in 49 specimens, endometritis in 8 specimens, endometrial polyps in 3 specimens and malignant endometrium in 10 specimens (one endometrial intra-epithelial neoplasia (EIN), 5 adenocarcinoma, 2 adenosquamous carcinoma, one endometrial adenosaroma, one mixed mullerian tumour (MMT)), Table 3 .
Discussion
Endometrial biopsy is an important step in the assessment of abnormal uterine bleeding to rule out endometrial carcinoma, so that medical or conservative surgery can be offered and unnecessary radical surgery can be avoided. Various methods of endometrial sampling are used in practice, including invasive and non-invasive on an inpatient or outpatient basis (8, 9) . D&C is an invasive inpatient procedure performed under general anesthesia. Pipelle device is used as outpatient noninvasive method gives adequate endometrial sample in 98% of cases and the probability of getting an adequate sample increases when central endometrial thickness is more than 5 mm (10, 11) , this is why patients with endometrial thickness <4 mm were excluded from this study, also, in this study, the samples obtained by Pipelle device were adequate for histopathological examination in 97.9%. A meta-analysis to assess the accuracy of endometrial sampling devices in detection of endometrial carcinoma and atypical hyperplasia was done by Dijkhuijen et al. (19) . They concluded that the endometrial biopsy with the Pipelle is superior to other endometrial techniques in detection of endometrial carcinoma and atypical hyperplasia in pre-and postmenopausal women. In this study; the Pipelle had 88.9% sensitivity, 99.2% NPV and it was 99.3% accurate for diagnosing endometritis, also, it had 60% sensitivity, 89.6% NPV and it was 98.6% accurate for diagnosing endometrial polyps, because the accuracy is high when an adequate endometrial sample is obtained and in this study, 3 specimens were reported as inadequate for histopathological evaluation (two of them were diagnosed as endometrial polyps and the other one was diagnosed as endometritis by conventional D&C). In this study, in spite of the low sensitivity of the Pipelle device for diagnosing endometritis and endometrial polyps (88.9% and 60%; respectively), it had a high negative predictive value (99.2% and 89.6%; respectively) and high accuracy (99.3% & 98.6%; respectively), also, Kuruvilla et al. (20) , found that the most common histological diagnosis missed with an inadequate endometrial sample was endometrial polyp. Three patients were excluded from this study due to failure to introduce the Pipelle through the cervix to get the endometrial sample (procedure failure), and the samples were obtained in those patients by D&C. No intra-operative or postoperative complications were recorded in this study, this leads to the conclusion that the endometrial sampling using Pipelle could replace the conventional D&C method of endometrial sampling, because, it is a safe, accurate, cost effective outpatient procedure, avoids general anesthesia with high sensitivity and specificity for detection of endometrial hyperplasia and endometrial carcinoma (6, 21) .
